Lead optimization study on indoline-2,3-dione derivatives as potential fatty acid amide hydrolase inhibitors

References

• Ahn, K., Johnson, D. S., & Cravatt, B. F. (2009). Fatty acid amide hydrolase as a potential therapeutic target for the treatment of pain and CNS disorders. Expert Opinion on Drug Discovery, 4(7), 763–784. https://doi.org/10.1517/17460440903018857
   PubMed Web of Science ®Google Scholar
• Bhuniya, D., Kharul, R. K., Hajare, A., Shaikh, N., Bhosale, S., Balwe, S., Begum, F., De, S., Athavankar, S., Joshi, D., Madgula, V., Joshi, K., Raje, A. A., Meru, A. V., Magdum, A., Mookhtiar, K. A., & Barbhaiya, R. (2019). Discovery and evaluation of novel FAAH inhibitors in neuropathic pain model. Bioorganic & Medicinal Chemistry Letters, 29(2), 238–243. https://doi.org/10.1016/j.bmcl.2018.11.048
   PubMed Web of Science ®Google Scholar
• Boger, D. L., Sato, H., Lerner, A. E., Hedrick, M. P., Fecik, R. A., Miyauchi, H., Wilkie, G. D., Austin, B. J., Patricelli, M. P., & Cravatt, B. F. (2000). Exceptionally potent inhibitors of fatty acid amide hydrolase: The enzyme responsible for degradation of endogenous oleamide and anandamide. Proceedings of the National Academy of Sciences of the United States of America, 97(10), 5044–5049. https://doi.org/10.1073/pnas.97.10.5044
   PubMed Web of Science ®Google Scholar
• Bowers, K. J., Chow, D. E., Xu, H., Dror, R. O., Eastwood, M. P., Gregersen, B. A., Klepeis, J. L., Kolossvary, I., Moraes, M. A., & Sacerdoti, F. D. (2006). Scalable algorithms for molecular dynamics simulations on commodity clusters. In SC’06: Proceedings of the 2006 ACM/IEEE Conference on Supercomputing, (IEEE) (p. 43).
   Google Scholar
• Bracey, M. H., Hanson, M. A., Masuda, K. R., Stevens, R. C., & Cravatt, B. F. (2002). Structural adaptations in a membrane enzyme that terminates endocannabinoid signaling. Science 80- (New York, N.Y.), 298(5599), 1793–1796. https://doi.org/10.1126/science.1076535
   PubMed Web of Science ®Google Scholar
• Chobanian, H. R., Guo, Y., Liu, P., Chioda, M. D., Fung, S., Lanza, T. J., Chang, L., Bakshi, R. K., Dellureficio, J. P., Hong, Q., McLaughlin, M., Belyk, K. M., Krska, S. W., Makarewicz, A. K., Martel, E. J., Leone, J. F., Frey, L., Karanam, B., Madeira, M., … DeVita, R. J. (2014). Discovery of MK-4409, a novel oxazole FAAH inhibitor for the treatment of inflammatory and neuropathic pain. ACS Medicinal Chemistry Letters, 5(6), 717–721. https://doi.org/10.1021/ml5001239
   PubMed Web of Science ®Google Scholar
• Di, L., Kerns, E. H., Fan, K., McConnell, O. J., & Carter, G. T. (2003). High throughput artificial membrane permeability assay for blood–brain barrier. European Journal of Medicinal Chemistry, 38(3), 223–232. https://doi.org/10.1016/S0223-5234(03)00012-6
   PubMed Web of Science ®Google Scholar
• Egan, W. J., Merz, K. M., & Baldwin, J. J. (2000). Prediction of drug absorption using multivariate statistics. Journal of Medicinal Chemistry, 43(21), 3867–3877. https://doi.org/10.1021/jm000292e
   PubMed Web of Science ®Google Scholar
• Gasteiger, J., & Marsili, M. (1980). Iterative partial equalization of orbital electronegativity—a rapid access to atomic charges. Tetrahedron, 36(22), 3219–3228. https://doi.org/10.1016/0040-4020(80)80168-2
   Web of Science ®Google Scholar
• Giang, D. K., & Cravatt, B. F. (1997). Molecular characterization of human and mouse fatty acid amide hydrolases. Proceedings of the National Academy of Sciences of the United States of America, 94(6), 2238–2242. https://doi.org/10.1073/pnas.94.6.2238
   PubMed Web of Science ®Google Scholar
• Gleeson, M. P. (2008). Generation of a set of simple, interpretable ADMET rules of thumb. Journal of Medicinal Chemistry, 51(4), 817–834. https://doi.org/10.1021/jm701122q
   PubMed Web of Science ®Google Scholar
• Griebel, G., Stemmelin, J., Lopez-Grancha, M., Fauchey, V., Slowinski, F., Pichat, P., Dargazanli, G., Abouabdellah, A., Cohen, C., & Bergis, O. E. (2018). The selective reversible FAAH inhibitor, SSR411298, restores the development of maladaptive behaviors to acute and chronic stress in rodents. Scientific Reports. 8, 1–25.
   PubMed Web of Science ®Google Scholar
• Hewawasam, P., & Meanwell, N. A. (1994). A general method for the synthesis of isatins: Preparation of regiospecifically functionalized isatins from anilines. Tetrahedron Letters. 35(40), 7303–7306. https://doi.org/10.1016/0040-4039(94)85299-5
   Web of Science ®Google Scholar
• Hughes, J. D., Blagg, J., Price, D. A., Bailey, S., Decrescenzo, G. A., Devraj, R. V., Ellsworth, E., Fobian, Y. M., Gibbs, M. E., Gilles, R. W., Greene, N., Huang, E., Krieger-Burke, T., Loesel, J., Wager, T., Whiteley, L., & Zhang, Y. (2008). Physiochemical drug properties associated with in vivo toxicological outcomes. Bioorganic & Medicinal Chemistry Letters, 18(17), 4872–4875. https://doi.org/10.1016/j.bmcl.2008.07.071
   PubMed Web of Science ®Google Scholar
• Jaiswal, S., & Raja Ayyannan, S. (2021). Discovery of isatin-based carbohydrazones as potential dual inhibitors of fatty acid amide hydrolase and monoacylglycerol lipase. ChemMedChem, 16(14), 2172–2187. https://doi.org/10.1002/cmdc.202100559
   PubMedGoogle Scholar
• Jaiswal, S., Tripathi, R. K. P., & Ayyannan, S. R. (2018). Scaffold hopping-guided design of some isatin based rigid analogs as fatty acid amide hydrolase inhibitors: Synthesis and evaluation. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie, 107, 1611–1623. https://doi.org/10.1016/j.biopha.2018.08.125
   PubMed Web of Science ®Google Scholar
• Jaiswal, S., Uniyal, A., Tiwari, V., Raja Ayyannan., & S., Akhilesh. (2022). Synthesis and evaluation of dual fatty acid amide hydrolase-monoacylglycerol lipase inhibition and antinociceptive activities of 4-methylsulfonylaniline-derived semicarbazones. Bioorganic & Medicinal Chemistry, 60, 116698. https://doi.org/10.1016/j.bmc.2022.116698
   PubMed Web of Science ®Google Scholar
• Kage, K. L., Richardson, P. L., Traphagen, L., Severin, J., Pereda-Lopez, A., Lubben, T., Davis-Taber, R., Vos, M. H., Bartley, D., Walter, K., Harlan, J., Solomon, L., Warrior, U., Holzman, T. F., Faltynek, C., Surowy, C. S., & Scott, V. E. (2007). A high throughput fluorescent assay for measuring the activity of fatty acid amide hydrolase. Journal of Neuroscience Methods, 161(1), 47–54. https://doi.org/10.1016/j.jneumeth.2006.10.006
   PubMed Web of Science ®Google Scholar
• Kansy, M., Fischer, H., Kratzat, K., Senner, F., Wagner, B., & Parrilla, I. (2001). High-throughput artificial membrane permeability studies in early lead discovery and development. In Testa, B., Van Waterbeemd, H., & Folk, G (Eds.), Pharmacokinetic Optimization in Drug Research: Biological, Physicochemical, and Computational Strategies (pp. 447–464). https://doi.org/10.1002/9783906390437.ch24.
   Google Scholar
• Kansy, M., Senner, F., & Gubernator, K. (1998). Physicochemical high throughput screening: Parallel artificial membrane permeation assay in the description of passive absorption processes. Journal of Medicinal Chemistry, 41(7), 1007–1010. https://doi.org/10.1021/jm970530e
   PubMed Web of Science ®Google Scholar
• Keith, J. M., Jones, W. M., Tichenor, M., Liu, J., Seierstad, M., Palmer, J. A., Webb, M., Karbarz, M., Scott, B. P., Wilson, S. J., Luo, L., Wennerholm, M. L., Chang, L., Rizzolio, M., Rynberg, R., Chaplan, S. R., & Breitenbucher, J. G. (2015). Preclinical characterization of the FAAH inhibitor JNJ-42165279. ACS Medicinal Chemistry Letters, 6(12), 1204–1208. https://doi.org/10.1021/acsmedchemlett.5b00353
   PubMed Web of Science ®Google Scholar
• Krall, R. L., Penry, J. K., White, B. G., Kupferberg, H. J., & Swinyard, E. A. (1978). Antiepileptic drug development: II. Anticonvulsant drug screening. Epilepsia, 19(4), 409–428. https://doi.org/10.1111/j.1528-1157.1978.tb04507.x
   PubMed Web of Science ®Google Scholar
• Lagorce, D., Sperandio, O., Baell, J. B., Miteva, M. A., & Villoutreix, B. O. (2015). FAF-Drugs3: a web server for compound property calculation and chemical library design. Nucleic Acids Research, 43(W1), W200–W207. https://doi.org/10.1093/nar/gkv353
   PubMed Web of Science ®Google Scholar
• Lahari, K., & Sundararajan, R. (2020). Design and synthesis of novel isatin derivatives as potent analgesic, anti-inflammatory and antimicrobial agents. Journal of Chemical Sciences. 132, 1–15.
   Web of Science ®Google Scholar
• Leonard, M. Z., Alapafuja, S. O., Ji, L., Shukla, V. G., Liu, Y., Nikas, S. P., Makriyannis, A., Bergman, J., & Kangas, B. D. (2017). Cannabinoid CB1 discrimination: Effects of endocannabinoids and catabolic enzyme inhibitors. The Journal of Pharmacology and Experimental Therapeutics, 363(3), 314–323. https://doi.org/10.1124/jpet.117.244392
   PubMed Web of Science ®Google Scholar
• Li, J., Abel, R., Zhu, K., Cao, Y., Zhao, S., & Friesner, R. A. (2011). The VSGB 2.0 model: A next generation energy model for high resolution protein structure modeling. Proteins, 79(10), 2794–2812. https://doi.org/10.1002/prot.23106
   PubMed Web of Science ®Google Scholar
• Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (1997). Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Advanced Drug Delivery Reviews, 23(1-3), 3–25. https://doi.org/10.1016/S0169-409X(96)00423-1
   Web of Science ®Google Scholar
• Lobell, M., Hendrix, M., Hinzen, B., Keldenich, J., Meier, H., Schmeck, C., Schohe‐Loop, R., Wunberg, T., & Hillisch, A. (2006). In silico ADMET traffic lights as a tool for the prioritization of HTS hits. ChemMedChem, 1(11), 1229–1236. https://doi.org/10.1002/cmdc.200600168
   PubMed Web of Science ®Google Scholar
• Long, J. Z., Nomura, D. K., Vann, R. E., Walentiny, D. M., Booker, L., Jin, X., Burston, J. J., Sim-Selley, L. J., Lichtman, A. H., Wiley, J. L., & Cravatt, B. F. (2009). Dual blockade of FAAH and MAGL identifies behavioral processes regulated by endocannabinoid crosstalk in vivo. Proceedings of the National Academy of Sciences of the United States of America, 106(48), 20270–20275. https://doi.org/10.1073/pnas.0909411106
   PubMed Web of Science ®Google Scholar
• Mandal, T., Dhara, K., Parui, N., & Dash, J. (2020). Domino relay olefin metathesis of triallyl oxindole and indole precursors to access cyclic indoxyls and carbazoles. ChemCatChem, 12(19), 4754–4759. https://doi.org/10.1002/cctc.202000813
   Web of Science ®Google Scholar
• Marvel, C. S., Hiers, G. S. (1925). Org Synth, 5, 71. https://doi.org/10.15227/orgsyn.005.0071
   Google Scholar
• Mathew, B., Haridas, A., Uçar, G., Baysal, I., Joy, M., Mathew, G. E., Lakshmanan, B., & Jayaprakash, V. (2016). Synthesis, biochemistry, and computational studies of brominated thienyl chalcones: A new class of reversible MAO‐B inhibitors. ChemMedChem, 11(11), 1161–1171. https://doi.org/10.1002/cmdc.201600122
   PubMed Web of Science ®Google Scholar
• McKinney, M. K., & Cravatt, B. F. (2003). Evidence for distinct roles in catalysis for residues of the serine-serine-lysine catalytic triad of fatty acid amide hydrolase. The Journal of Biological Chemistry, 278(39), 37393–37399. https://doi.org/10.1074/jbc.M303922200
   PubMed Web of Science ®Google Scholar
• Mileni, M.,Johnson, D. S.,Wang, Z.,Everdeen, D. S.,Liimatta, M.,Pabst, B.,Bhattacharya, K.,Nugent, R. A.,Kamtekar, S.,Cravatt, B. F.,Ahn, K., &Stevens, R. C. (2008). Structure-guided inhibitor design for human FAAH by interspecies active site conversion. Proceedings of the National Academy of Sciences of the United States of America, 105(35), 12820–12824. 10.1073/pnas.0806121105 18753625
   PubMed Web of Science ®Google Scholar
• Mor, M., Rivara, S., Lodola, A., Plazzi, P. V., Tarzia, G., Duranti, A., Tontini, A., Piersanti, G., Kathuria, S., & Piomelli, D. (2004). Cyclohexylcarbamic acid 3 ‘-or 4 ‘-substituted biphenyl-3-yl esters as fatty acid amide hydrolase inhibitors: synthesis, quantitative structure − activity relationships, and molecular modeling studies. Journal of Medicinal Chemistry, 47(21), 4998–5008. https://doi.org/10.1021/jm031140x
   PubMed Web of Science ®Google Scholar
• Pandeya, S. N., Raja, A. S., & Nath, G. (2006). Synthesis and antimicrobial evaluation of some 4-or 6-chloroisatin derivatives. Indian Journal of Chemistry Section B, 45B(2), 494–499.
   Google Scholar
• Patricelli, M. P., & Cravatt, B. F. (1999). Fatty acid amide hydrolase competitively degrades bioactive amides and esters through a nonconventional catalytic mechanism. Biochemistry, 38(43), 14125–14130. https://doi.org/10.1021/bi991876p
   PubMed Web of Science ®Google Scholar
• Porter, R. J., Cereghino, J., Gladding, G. D., Hessie, B. J., Kupferberg, H. J., Scoville, B., & White, B. G. (1984). Antiepileptic drug development program. Cleveland Clinic Quarterly, 51(2), 293–305. https://doi.org/10.3949/ccjm.51.2.293
   PubMedGoogle Scholar
• Shaikh, M. H., Subhedar, D. D., Khan, F. A. K., Sangshetti, J. N., Nawale, L., Arkile, M., Sarkar, D., & Shingate, B. B. (2017). Synthesis of novel triazole‐incorporated isatin derivatives as antifungal, antitubercular, and antioxidant agents and molecular docking study. Journal of Heterocyclic Chemistry, 54(1), 413–421. https://doi.org/10.1002/jhet.2598
   Web of Science ®Google Scholar
• Treijtel, N., Collins, C., van Bruijnsvoort, M., Fuhr, R., Ernault, E., Gangaram‐Panday, S., & Passier, P. (2019). A cocktail interaction study evaluating the drug‐drug interaction potential of the perpetrator drug ASP8477 at multiple ascending dose levels. Clinical Pharmacology in Drug Development, 8(4), 529–540. https://doi.org/10.1002/cpdd.660
   PubMed Web of Science ®Google Scholar
• Tripathi, R. K. P., & Ayyannan, S. R. (2020). Exploration of dual fatty acid amide hydrolase and cholinesterase inhibitory potential of some 3‐hydroxy‐3‐phenacyloxindole analogs. Archiv Der Pharmazie, 353(9), 2000036. https://doi.org/10.1002/ardp.202000036
   Web of Science ®Google Scholar
• Veber, D. F., Johnson, S. R., Cheng, H.-Y., Smith, B. R., Ward, K. W., & Kopple, K. D. (2002). Molecular properties that influence the oral bioavailability of drug candidates. Journal of Medicinal Chemistry, 45(12), 2615–2623. https://doi.org/10.1021/jm020017n
   PubMed Web of Science ®Google Scholar